GCPL has completed the acquisition of Strength of Nature
Godrej Consumer Products Ltd (GCPL) has completed the acquisition of US based Strength of Nature LLC after getting approval from the Federal Trade Commission and
Home
Page 4620
Canara Bank has raised Rs 3,000 crore by issuing Basel-III compliant bonds
Canara Bank, the public sector lender has raised Rs 3,000 crore through issuing Basel-III compliant tier-II bonds to boost capital base and fund growth. Canara
Torrent Pharma has recalled 20,952 cartons of hypertension drug in US
Torrent Pharma which is based at Ahmedabad has been recalling 20,952 cartons of Telmisartan tablets that are used in the treatment of hypertension in US
Infosys has invested in Trifacta
The second largest IT services firm of country Infosys has invested an undisclosed amount in the US-based Trifacta. Trifacta provides data wrangling software that enables
HCL Tech reports Q3 net increase of 14.4% to Rs 1,926 crore
HCL Technologies has reported a 14.4 percent rise in the net profit at Rs 1,926 crore for the quarter ended March. HCL Technologies has said
Share Market Tips for – Thursday, April 28, 2016
Market To See Sharp Positive Movement, Hold Long Positions Last Trading Session: Exactly as predicted by EquityPandit, Indian Stock Market opened flat for the
Nandan Nilekani, the co-founder of Infosys has invested in RailYatri
Nandan Nilekani who is the co-founder of Infosys, has invested an undisclosed amount in the train travel app RailYatri.in. RailYatri said in a statement that
Adani Australian coal mine approval has to face fresh court challenge
The Supreme Court of Queensland has been asked by a green group to review the environment approval that has been granted to the Indian conglomerate
Larsen & Toubro’s arm has received Rs 1,798 crore orders in April
The construction arm of Larsen & Toubro (L&T) has received orders worth Rs 1,798 crore across various business verticals in April. The company has said
Aurobindo Pharma has received USFDA approval for two drugs
Aurobindo Pharma has got the USFDA final approval for manufacturing and marketing the generic version of heartburn relief medicine Famotidine tablets. The company has said